Physician profile
Mitchell D Weinberg
NPI 1245498385
$144,596.90
in general payments reported to CMS, 2019-2025
27 companies · $28K in 2025
The $28K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,660 · 2021: $12K · 2022: $19K · 2023: $38K · 2024: $26K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $10K · Travel and Lodging: $5,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $57,313.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,550.00 |
| Food and Beverage | $10,396.20 |
| Travel and Lodging | $5,580.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $115,056.73 | 2019-2025 | General - Therapies, Ekosonic, Clinical Trial Product |
| Medtronic Vascular, INC. | $8,475.46 | 2019-2020 | |
| Neptune Medical INC. | $5,188.18 | 2023 | |
| Janssen Pharmaceuticals, INC | $4,160.92 | 2020-2021 | |
| Medtronic, INC. | $3,959.41 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Endologix LLC | $1,578.04 | 2024-2025 | Torus Stent Graft System, Endocross Device |
| Cardiovascular Systems INC. | $1,338.85 | 2019-2023 | Diamondback Coronary |
| Abbott Laboratories | $1,193.07 | 2021-2025 | Mitraclip, Aveir, Gallant |
| Philips North America LLC | $610.99 | 2022-2024 | (Bq9) Coronary Ivus, (6571) Eagle Eye |
| Siemens Medical Solutions USA, INC. | $486.89 | 2019-2024 | Artis Icono Floor |
| Microvention, INC. | $400.00 | 2021 | |
| Cook Medical LLC | $263.88 | 2019-2020 | |
| Bolton Medical INC | $256.24 | 2019 | |
| Shockwave Medical, INC | $250.46 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $250.00 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $170.58 | 2019 | |
| Penumbra, INC. | $161.58 | 2019-2022 | |
| Edwards Lifesciences Corporation | $153.97 | 2023 | Inspiris Resilia Aortic Valve |
| Sirtex Medical INC | $134.48 | 2023 | Sir-Spheres Microspheres |
| Astrazeneca Pharmaceuticals LP | $132.29 | 2020 | |
| Acist Medical Systems, INC. | $123.74 | 2019 | |
| W. L. Gore & Associates, INC. | $100.47 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cordis US Corp. | $62.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $42.33 | 2023 | |
| Inari Medical, INC. | $28.25 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.83 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Weinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.